Cardiac Imaging in the Post-ISCHEMIA Trial Era

Autor:	Donna M. Polk, Raymond Y. Kwong, Farouc A. Jaffer, Mouaz H. Al-Mallah, Rob S. Beanlands, Ehtisham Mahmud, Sven Plein, Eike Nagel, Michael Salerno, David A. Cox, Timothy D. Henry, Colin Berry, Ron Blankstein, Patricia A. Pellikka, Partho P. Sengupta, Vasken Dilsizian, Paul A. Grayburn, John P Greenwood, Madhav Swaminathan, Kirk N. Garrett, Andrew E. Arai, Sunil V. Rao, Cindy Grines, William A. Zoghbi, Venkatesh L. Murthy, Dennis A. Calnon, James C. Carr, Sharmila Dorbala, Frank A. Flachskampf, Peter L. Duffy, Chiara Bucciarelli-Ducci, Leslee J. Shaw, Koen Nieman, Y S Chandrashekhar, Randall C. Thompson, Terrence D. Ruddy, Prem Soman, Thomas H. Marwick, Subha V. Raman, Jonathan Leipsic
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry Ischemia MEDLINE 030204 cardiovascular system & hematology medicine.disease 030218 nuclear medicine & medical imaging Clinical trial 03 medical and health sciences Management strategy 0302 clinical medicine medicine Radiology Nuclear Medicine and imaging Cardiology and Cardiovascular Medicine business Intensive care medicine Medical therapy Cardiac imaging
Zdroj:	JACC: Cardiovascular Imaging. 13:1815-1833
ISSN:	1936-878X
DOI:	10.1016/j.jcmg.2020.05.001
Popis:	The highly anticipated ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, the largest study to-date conducted to assess for the incremental clinical benefits of an initial invasive management strategy over an initial medical therapy
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::10a33f7aa53e9f78045d07a02aca27ec https://doi.org/10.1016/j.jcmg.2020.05.001 Zobrazit plný text záznamu